FDA warning public of risks of online pharmacies

by The Associated Press

The Food and Drug Administration is warning the public that most Internet pharmacies are fraudulent, selling drugs that likely are counterfeit and could harm or even kill people.

So the FDA has just launched a national campaign, called BeSafeRx, to alert the public to the danger.

A recent survey by the agency found nearly one in four Internet shoppers has bought prescription drugs online.

Most don't realize that only about 3 percent of are licensed and following the law. The rest likely are selling that won't help patients get better and may contain arsenic or other poisons.

A new website, at www.FDA.gov/BeSafeRx , shows people how to find safe online pharmacies. The FDA is working with other government agencies, doctors and pharmacists to spread the word.

not rated yet
add to favorites email to friend print save as pdf

Related Stories

Google to settle drug probe for $500 million

Aug 24, 2011

Google will pay $500 million to settle charges that it sold advertisements to Canada-based online pharmacies which marketed drugs to Americans in violation of US law, US justice officials announced Wednesday.

Investors to get Google records on online drug ads

Mar 09, 2012

(AP) -- A Delaware judge has given Google Inc. until April 9 to give a pension fund investors company documents involving what authorities said was the illegal online marketing of prescription drugs to U.S. consumers by ...

Recommended for you

FDA approves hard-to-abuse narcotic painkiller

Jul 25, 2014

(HealthDay)—A new formulation of a powerful narcotic painkiller that discourages potential abusers from snorting or injecting the drug has been approved by the U.S. Food and Drug Administration.

Race affects opioid selection for cancer pain

Jul 25, 2014

(HealthDay)—Racial disparities exist in the type of opioid prescribed for cancer pain, according to a study published online July 21 in the Journal of Clinical Oncology.

FDA approves tough-to-abuse formulation of oxycodone

Jul 25, 2014

(HealthDay)—Targiniq ER (oxycodone hydrochloride and naloxone hydrochloride extended release) has been approved by the U.S. Food and Drug Administration as a long-term, around-the-clock treatment for severe ...

Tough-to-abuse formulation of oxycodone approved

Jul 25, 2014

(HealthDay)—Targiniq ER (oxycodone hydrochloride and naloxone hydrochloride extended release) has been approved by the U.S. Food and Drug Administration as a long-term, around-the-clock treatment for severe pain when other ...

EU regulator: Morning-after pill OK for all women

Jul 24, 2014

(AP)—A commonly used morning-after pill is suitable for use by heavier women, the European Medicines Agency said Thursday after a review of the evidence sparked by the French manufacturer's declaration that the drugs didn't ...

Physicians warned about counterfeit medical devices

Jul 24, 2014

(HealthDay)—Physicians should be aware of the prevalence and serious consequences associated with use of counterfeit medical devices, according to a letter to the editor published online July 20 in Lasers in ...

User comments